No definition available.
Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)
C3_DLBCL_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
1538 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1538 |
4. Check minimum number of eventsNone |
1538 |
5. Include endpoints |
1538 |
6. Filter based on genotype QC (FinnGen only) |
1538 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
- Control conditions
- not HLP_C3_DLBCL
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Diffuse large B-cell lymphoma, helper endpoint
- Diffuse large B-cell lymphoma
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1538 | 679 | 859 |
| Unadjusted period prevalence (%) | 0.31 | 0.23 | 0.38 |
| Median age at first event (years) | 67.80 | 66.58 | 68.77 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1413
- Matched controls
- 14129
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
6785.1
323.0
474
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1162.1
323.0
1225
79
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
323.0
1308
*
A03FA01
ATC
metoclopramide; systemic, rectal
32.3
323.0
915
759
A04AA02
ATC
granisetron; systemic, transdermal
2210.6
323.0
330
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
323.0
555
*
JN4BD
NOMESCO Finland
Extensive body CT
41.1
323.0
689
320
A04AA01
ATC
ondansetron; systemic, rectal
60.7
323.0
430
101
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
323.0
629
*
XW000
NOMESCO Finland
Bone marrow biopsy
49.6
323.0
494
151
L03AA02
ATC
filgrastim; parenteral
2677.6
323.0
507
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
323.0
321
*
M04AA01
ATC
allopurinol; systemic
12.2
323.0
769
1256
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
5530.6
323.0
412
*
WW500
NOMESCO Finland
Blood transfusion
50.1
316.4
383
104
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
304.4
281
*
JN4AD
NOMESCO Finland
Body CT examination
27.1
275.9
391
196
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
255.1
237
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
252.8
235
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
696.5
243.8
234
*
H02AB02
ATC
dexamethasone; systemic
67.2
241.3
277
51
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
234.0
218
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
227.3
212
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
325.3
222.3
220
8
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
35.6
217.4
284
99
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
217.4
203
*
ZX120
NOMESCO Finland
Intravenous
12.0
212.8
424
486
H02AB06
ATC
prednisolone; systemic
6.3
212.6
1074
4710
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
15.3
201.5
352
299
1XC02
NOMESCO Finland
NA
135.2
197.3
208
18
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
192.6
194.3
199
12
A49.9
ICD-10 Finland
Bacterial infection, unspecified
9.1
191.4
454
701
JN6AD
NOMESCO Finland
CT of torso and neck
112.0
187.9
202
21
WF003
NOMESCO Finland
Adjuvant radiotherapy
688.0
187.3
181
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
183.4
172
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.6
179.1
697
2092
N02AA05
ATC
oxycodone; systemic
7.6
179.1
485
909
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
35.3
177.6
232
78
WF002
NOMESCO Finland
Radical radiotherapy
281.1
172.7
173
7
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
168.1
158
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
257.2
158.7
160
7
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
146.4
138
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
141.6
144.3
152
12
XX3DW
NOMESCO Finland
Time consuming IT work
11.3
138.8
277
297
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
497.7
138.7
136
*
A02BC02
ATC
pantoprazole; systemic
4.9
137.7
1164
6897
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
256.4
137.6
139
6
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
97.9
136.1
149
17
R50.9
ICD-10 Finland
Fever, unspecified
6.2
132.1
408
866
Z51.5
ICD-10 Finland
Palliative care
20.7
130.5
199
111
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
121.6
115
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
120.5
114
*
ZX112
NOMESCO Finland
Subcutaneous
58.6
117.3
138
26
C61
ICD-10 Finland
Malignant neoplasm of prostate
401.4
113.1
112
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
113.0
107
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
39.4
109.4
139
39
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
107.7
102
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
103.3
876
4565
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
350.2
97.2
97
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
18.5
96.9
153
92
ZX070
NOMESCO Finland
Intensity modified radiotherapy
946.9
91.9
89
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.7
88.7
345
905
WF004
NOMESCO Finland
Palliative radiotherapy
878.9
85.5
83
*
WZC30
NOMESCO Finland
Teaching
5.2
85.0
294
677
H02AB07
ATC
prednisone; oral
4.1
81.9
371
1119
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
26.8
81.8
114
46
J05AB11
ATC
valaciclovir; oral
4.5
80.0
323
870
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
79.9
76
*
L01CB01
ATC
etoposide; systemic
+∞
78.9
75
*
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
76.7
73
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
76.7
73
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
76.7
73
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
8.3
74.9
175
236
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
88.1
74.9
83
10
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
73.6
70
*
130
Kela drug reimbursment
Malignant tumour
+∞
72.5
69
*
B01AB05
ATC
enoxaparin; parenteral
3.0
72.2
568
2586
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
+∞
71.4
68
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
9.7
71.3
151
172
JN4CD
NOMESCO Finland
Very extensive body CT
14.4
70.9
123
93
B01AB10
ATC
tinzaparin; parenteral
7.4
70.8
179
272
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
16.1
70.1
116
78
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
69.3
66
*
212
Kela drug reimbursment
Gout
11.9
68.7
130
119
D70.89
ICD-10 Finland
Neutropenic splenomegaly
37.0
67.8
87
25
J01MA12
ATC
levofloxacin; systemic
3.4
67.7
395
1441
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
667.5
65.4
64
*
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
+∞
64.0
61
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.9
62.8
187
353
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
61.8
463
1994
ZX090
NOMESCO Finland
Other technic of radiotherapy
320.9
60.8
61
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.1
58.9
200
439
116
Kela drug reimbursment
Prostate cancer
+∞
58.7
56
*
B72
ICPC
Hodgkin Lymphoma
+∞
57.7
55
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
56.6
54
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
55.6
53
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
81.0
55.4
62
8
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
32.9
54.8
72
23
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
281.2
53.5
54
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.0
52.4
98
87
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
52.4
50
*
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
+∞
50.3
48
*
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
50.3
48
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
50.3
48
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
258.8
49.4
50
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
49.2
47
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.6
48.3
247
791
9680/3-C77.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck
+∞
48.2
46
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.5
47.7
149
295
A41.9
ICD-10 Finland
Sepsis, unspecified
7.1
47.4
121
184
TAB00
NOMESCO Finland
Lumbar puncture
6.3
46.8
131
226
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
46.7
387
1723
115
Kela drug reimbursment
Breast cancer
+∞
46.1
44
*
D64.9
ICD-10 Finland
Anaemia, unspecified
3.5
45.9
242
791
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
461.7
45.5
45
*
N02BE01
ATC
paracetamol; systemic, rectal
3.0
45.5
1251
10204
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
44.0
42
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.5
43.7
440
2173
A79
ICPC
Malignancy NOS
118.7
43.0
46
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
42.9
41
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.1
41.9
119
209
WW409
NOMESCO Finland
Other aferesis
419.1
41.3
41
*
ZX080
NOMESCO Finland
Image guided radiotherapy
419.1
41.3
41
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
41.2
210
665
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
40.8
39
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.8
40.8
144
326
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.6
40.1
122
233
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
39.8
38
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
+∞
39.8
38
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
38.7
37
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
8.5
38.4
86
107
TPX15
NOMESCO Finland
Removal of vascular injection port
137.0
37.9
40
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.6
37.6
78
85
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
37.0
314
1390
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
15.6
36.4
60
40
TGC00
NOMESCO Finland
Bronchial lavation
6.7
36.0
95
151
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.7
36.0
167
488
J05AB01
ATC
aciclovir; systemic
2.5
35.8
336
1570
HA1AA
NOMESCO Finland
X-ray mammography
7.7
35.8
85
116
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
35.6
34
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
35.6
34
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
7.2
35.0
87
127
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
97.5
34.9
38
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
33.1
34.6
45
14
A04AA55
ATC
palonosetron, combinations; systemic
+∞
34.5
33
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
12.4
33.6
61
51
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
33.5
32
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
33.5
32
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
33.5
32
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
33.5
32
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
11.5
33.4
63
57
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
33.0
484
2785
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
334.4
33.0
33
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
173.9
32.8
34
*
A07AA02
ATC
nystatin; oral
3.8
32.7
146
412
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
50.0
32.6
39
8
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
32.4
31
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
32.4
31
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.2
32.2
187
648
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
35.1
32.0
41
12
D69.5
ICD-10 Finland
Secondary thrombocytopenia
44.4
31.9
39
9
H02AB09
ATC
hydrocortisone; systemic
8.1
31.9
73
94
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
31.9
465
2661
L02AE02
ATC
leuprorelin; implant, parenteral
31.6
30.4
40
13
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
30.3
29
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
11.8
30.3
56
49
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
19.3
29.7
45
24
WX110
NOMESCO Finland
Local anesthesy
1.9
29.2
903
6795
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
11.2
28.9
55
51
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
28.8
153
496
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
105.5
28.7
31
*
Z51.0
ICD-10 Finland
Radiotherapy session
153.0
28.7
30
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
28.7
417
2360
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
28.6
343
1784
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
28.2
27
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
28.2
27
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
27.8
28.1
38
14
C03CA01
ATC
furosemide; systemic
2.0
28.0
522
3258
Y77
ICPC
Malignant neoplasm prostate
286.7
27.8
28
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
286.7
27.8
28
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
10.5
27.6
54
53
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
48.2
27.5
33
7
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
35.8
27.5
35
10
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
35.8
27.5
35
10
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
275.9
26.8
27
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
26.5
148
496
KA1FN
NOMESCO Finland
Isotope renography
29.8
26.4
35
12
ZX108
NOMESCO Finland
Inhalation
21.6
26.1
38
18
9680/3-C77.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes
+∞
26.1
25
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
26.1
25
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
26.1
25
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
26.1
25
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.0
26.1
73
126
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
25.9
663
4587
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.9
25.7
86
183
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
25.6
199
824
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
49.2
24.3
29
6
3AA13
NOMESCO Finland
NA
+∞
24.0
23
*
L02BB03
ATC
bicalutamide; oral
+∞
24.0
23
*
E83.50
ICD-10 Finland
Hypercalcemia
10.3
23.9
47
47
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
68.6
23.9
27
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
23.8
257
1260
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
31.6
23.7
31
10
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
31.6
23.7
31
10
J01MA14
ATC
moxifloxacin; systemic
2.8
23.7
161
613
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
7.0
23.2
58
86
GD1AD
NOMESCO Finland
Thorax CT examination
4.3
23.0
88
215
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
+∞
23.0
22
*
9680/3-C17.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of small intestine, NOS
+∞
23.0
22
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
23.3
22.6
32
14
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
21.1
22.6
33
16
ZXD05
NOMESCO Finland
Urgent procedure
1.9
22.3
450
2833
Z2446
NOMESCO Finland
Social worker
3.3
22.1
119
388
JFB00
NOMESCO Finland
Partial resection of small intestine
8.5
22.0
48
58
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
21.9
21
*
ZX131
NOMESCO Finland
Intrathecal
+∞
21.9
21
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
18.7
21.8
33
18
J01DB01
ATC
cefalexin; oral
1.8
21.4
1095
9189
WX882
NOMESCO Finland
High dependency care
5.1
21.4
69
142
R4190
NOMESCO Finland
Nutritional therapy
6.7
21.1
54
83
WX002
NOMESCO Finland
Sedation and analgesia
2.0
21.0
315
1772
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
28.5
21.0
28
10
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
10.8
20.9
40
38
127
Kela drug reimbursment
Transplant complication
9.8
20.9
42
44
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
20.9
20
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
20.9
20
*
A04AD12
ATC
aprepitant; systemic
+∞
20.9
20
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
21.8
20.8
30
14
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
212.8
20.6
21
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
111.6
20.6
22
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
111.6
20.6
22
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.6
20.4
96
282
R4110
NOMESCO Finland
Physiotherapy
1.9
20.1
367
2217
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
17.6
20.0
31
18
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
58.3
19.9
23
*
WW200
NOMESCO Finland
Immunization
4.8
19.8
67
145
9680/3-C42.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of spleen
+∞
19.8
19
*
9680/3-C34.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lung, NOS
+∞
19.8
19
*
9680/3-C77.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
19.8
19
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
19.8
19
*
9680/3-C49.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck
+∞
19.8
19
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.1
19.8
63
128
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
8.8
19.7
42
49
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.3
19.7
61
120
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
29.4
19.7
26
9
HAC20
NOMESCO Finland
Total mastectomy
106.5
19.6
21
*
C50.99
ICD-10 Finland
Breast, unspecified
202.6
19.6
20
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
19.4
538
3712
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.0
19.2
62
128
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
5.5
19.2
57
107
WX402
NOMESCO Finland
General anaesthesia
2.3
19.0
198
950
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
6.8
19.0
48
73
JMA10
NOMESCO Finland
Transabdominal total splenectomy
34.8
18.9
24
7
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
18.8
18
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
18.8
18
*
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
18.8
18
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
18.8
18
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.1
18.8
74
187
ZXE00
NOMESCO Finland
One hour or less
1.7
18.7
531
3675
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.8
18.7
63
136
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
18.7
152
643
L02BG04
ATC
letrozole; oral
24.0
18.7
26
11
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
101.3
18.6
20
*
TGD00
NOMESCO Finland
Needle biopsy of lung
38.9
18.6
23
6
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
192.3
18.6
19
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
18.4
128
494
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
18.4
123
463
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
30.5
18.4
24
8
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
18.1
250
1355
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
20.3
17.8
26
13
WW402
NOMESCO Finland
Leucoferesis
+∞
17.7
17
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
17.7
445
2961
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
12.6
17.6
31
25
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
29.2
17.4
23
8
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
42.5
17.3
21
5
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
50.6
17.0
20
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
25.9
16.9
23
9
Z3231
NOMESCO Finland
Registered nurse
1.8
16.8
374
2392
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
16.8
151
673
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
16.7
16
*
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
+∞
16.7
16
*
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
+∞
16.7
16
*
9680/3-C18.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of cecum
+∞
16.7
16
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
16.7
16
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
16.7
16
*
TQW99
NOMESCO Finland
Other minor procedure on skin
3.6
16.6
75
214
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
91.1
16.6
18
*
1CX01
NOMESCO Finland
NA
91.1
16.6
18
*
EMA10
NOMESCO Finland
Biopsy of tonsil
27.9
16.5
22
8
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
11.3
16.3
30
27
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.5
16.3
38
52
B02.9
ICD-10 Finland
Zoster without complication
2.7
16.2
112
431
A06AH03
ATC
naloxegol; oral
21.2
16.0
23
11
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
15.7
479
3343
Z2221
NOMESCO Finland
Medical doctor
1.7
15.7
357
2289
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
15.6
15
*
9680/3-C77.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm
+∞
15.6
15
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
15.6
15
*
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
15.6
15
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.5
15.4
55
127
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
5.4
15.0
45
86
N02AX02
ATC
tramadol; systemic, rectal
1.6
15.0
573
4231
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.7
14.9
66
186
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
14.6
14
*
1BC01
NOMESCO Finland
NA
+∞
14.6
14
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
14.6
14
*
9680/3-C38.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS
+∞
14.6
14
*
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
14.6
14
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
14.6
14
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
80.9
14.6
16
*
A06AD11
ATC
lactulose; oral
1.9
14.6
224
1258
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
151.4
14.5
15
*
C90.0
ICD-10 Finland
Multiple myeloma
151.4
14.5
15
*
L01AA02
ATC
chlorambucil; oral
151.4
14.5
15
*
L57.0
ICD-10 Finland
Actinic keratosis
2.4
14.4
129
573
ZXA00
NOMESCO Finland
Right side
1.7
14.3
387
2601
N03AX16
ATC
pregabalin; oral
1.7
14.2
316
2008
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
42.9
14.1
17
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.9
14.1
39
68
WX704
NOMESCO Finland
Intubation
2.7
13.9
94
358
N05CF01
ATC
zopiclone; oral
1.6
13.8
451
3184
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.1
13.6
77
259
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
75.8
13.6
15
*
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
+∞
13.6
13
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
13.6
13
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
13.6
13
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
13.6
13
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
13.6
13
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
13.6
13
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
6.4
13.5
35
56
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
34.4
13.5
17
5
Z52.89
ICD-10 Finland
Donor of other organ or tissue
141.2
13.5
14
*
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
141.2
13.5
14
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
141.2
13.5
14
*
UJF32
NOMESCO Finland
Coloscopy
1.7
13.3
349
2317
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
6.2
13.2
35
58
A07AA09
ATC
vancomycin; oral
6.9
13.2
32
47
R11
ICD-10 Finland
Nausea and vomiting
2.4
13.1
111
478
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
8.9
13.0
27
31
JAH01
NOMESCO Finland
Laparoscopy
3.6
12.8
58
167
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.2
12.8
48
117
HAB40
NOMESCO Finland
Wedge excision of mammary gland
12.4
12.6
22
18
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
70.5
12.6
14
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
32.3
12.6
16
5
ENA10
NOMESCO Finland
Biopsy of pharynx
32.3
12.6
16
5
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
32.3
12.6
16
5
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
8.3
12.6
27
33
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
12.5
12
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
12.5
12
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
12.5
12
*
L01BC06
ATC
capecitabine; oral
+∞
12.5
12
*
9680/3-C49.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
12.5
12
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
12.5
12
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
+∞
12.5
12
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
12.5
12
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.0
12.5
72
248
WF099
NOMESCO Finland
Other radiotherapy
131.0
12.4
13
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
5.6
12.3
35
64
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.0
12.2
48
123
J94.8
ICD-10 Finland
Other specified pleural conditions
5.5
12.1
35
65
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.5
12.0
42
96
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
11.1
12.0
22
20
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
13.5
11.9
20
15
R06AE07
ATC
cetirizine; oral
1.5
11.9
496
3685
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.6
11.9
89
360
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
5.2
11.9
36
71
ZZR00
NOMESCO Finland
Flap of skin
10.6
11.8
22
21
SPAT1153
SPAT
Removal of sutures
1.6
11.7
436
3148
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
30.3
11.6
15
5
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
7.8
11.6
26
34
KCD02
NOMESCO Finland
Transurethral resection of bladder
12.7
11.6
20
16
L02BA01
ATC
tamoxifen; oral
65.5
11.6
13
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
65.5
11.6
13
*
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
11.5
11
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
11.5
11
*
9680/3-C17.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of ileum
+∞
11.5
11
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
11.5
11
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
11.5
11
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
11.5
11
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
11.5
11
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
11.5
11
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
11.5
11
*
JFB30
NOMESCO Finland
Right hemicolectomy
7.5
11.4
26
35
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
120.9
11.4
12
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
7.9
11.4
25
32
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
15.2
11.3
18
12
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.2
11.3
59
191
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
17.2
11.2
17
10
GEA00
NOMESCO Finland
Mediastinoscopy
17.2
11.2
17
10
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
20.2
11.1
16
8
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
10.1
11.0
21
21
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
14.0
11.0
18
13
WX892
NOMESCO Finland
Monitored bed care
2.2
10.9
119
579
B03XA02
ATC
darbepoetin alfa; parenteral
5.1
10.8
33
66
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
10.8
325
2221
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.4
10.8
89
381
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
10.7
236
1484
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.7
10.7
74
286
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
5.7
10.4
29
52
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
110.7
10.4
11
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
110.7
10.4
11
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
10.4
10
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
10.4
10
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
10.4
10
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
+∞
10.4
10
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
10.4
10
*
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
10.4
10
*
L02BX02
ATC
degarelix; parenteral
+∞
10.4
10
*
9680/3-C50.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of breast, NOS
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
9680/3-C49.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
10.4
10
*
9680/3-C17.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of duodenum
+∞
10.4
10
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
10.4
10
*
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
+∞
10.4
10
*
AA1AD
NOMESCO Finland
CT of head and brain
1.6
10.3
356
2514
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
18.9
10.3
15
8
UKC02
NOMESCO Finland
Cystoscopy
1.7
10.2
214
1324
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
7.0
10.1
24
35
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
14.7
10.0
16
11
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
40.3
10.0
12
*
ZX121
NOMESCO Finland
Central venous catheter
40.3
10.0
12
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
40.3
10.0
12
*
N03AX14
ATC
levetiracetam; systemic
3.6
10.0
44
126
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.7
9.9
66
249
B01AB04
ATC
dalteparin; parenteral
2.7
9.9
68
264
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
16.8
9.9
15
9
B02
ICPC
Lymph gland(s) enlarged/painful
12.3
9.9
17
14
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.4
9.8
34
78
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
26.2
9.8
13
5
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.8
9.8
61
222
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.9
9.6
30
62
ZXC95
NOMESCO Finland
Use of surgical navigator
6.4
9.6
24
38
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.0
9.5
52
175
G04BE03
ATC
sildenafil; oral
9.1
9.5
19
21
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
7.2
9.5
22
31
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
100.6
9.4
10
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
100.6
9.4
10
*
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
30.2
9.4
12
*
AAF30
NOMESCO Finland
Implantation of intraventricular injection device
+∞
9.4
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.4
9
*
9680/3-C07.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of parotid gland
+∞
9.4
9
*
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
+∞
9.4
9
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
9.4
9
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
9.4
9
*
L01BB05
ATC
fludarabine; systemic
+∞
9.4
9
*
1DB01
NOMESCO Finland
NA
+∞
9.4
9
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
9.4
9
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
9.4
9
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
9.4
9
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
5.4
9.4
27
51
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.4
9.4
44
133
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
9.3
243
1596
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.6
9.1
63
247
A41.8
ICD-10 Finland
Other specified sepsis
4.1
9.1
34
85
JAH00
NOMESCO Finland
Laparotomy
3.9
9.0
36
95
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
9.1
9.0
18
20
J02AC03
ATC
voriconazole; systemic
36.9
9.0
11
*
CKA10
NOMESCO Finland
Biopsy of vitreous body
36.9
9.0
11
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.9
9.0
53
188
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.0
8.9
51
176
C10AA07
ATC
rosuvastatin; oral
0.6
8.9
178
2674
R50.8
ICD-10 Finland
Other specified fever
12.6
8.9
15
12
WX720
NOMESCO Finland
Own respiration
2.7
8.8
57
214
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
10.8
8.8
16
15
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
8.7
69
288
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
8.7
217
1405
TK800
NOMESCO Finland
Hemodialysis
3.6
8.7
38
109
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.2
8.6
31
75
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
11.6
8.6
15
13
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.6
8.6
62
248
J01MA02
ATC
ciprofloxacin; systemic
1.4
8.6
493
3854
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.8
8.6
27
57
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
16.4
8.6
13
8
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
10.1
8.5
16
16
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
27.7
8.5
11
*
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
27.7
8.5
11
*
C50
ICD-10 Finland
Malignant neoplasm of breast
90.5
8.4
9
*
XX1AD
NOMESCO Finland
Other CT-examination
90.5
8.4
9
*
Z94.1
ICD-10 Finland
Heart transplant status
12.8
8.4
14
11
C85.0
ICD-10 Finland
Lymphosarcoma
+∞
8.3
8
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
8.3
8
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
8.3
8
*
9680/3-C49.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax
+∞
8.3
8
*
9680/3-C64.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of kidney, NOS
+∞
8.3
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.3
8
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
8.3
8
*
OAA41
NOMESCO Finland
Health check based on individual needs
+∞
8.3
8
*
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
+∞
8.3
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
9680/3-C48.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of retroperitoneum
+∞
8.3
8
*
9680/3-C11.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS
+∞
8.3
8
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
8.3
8
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
8.3
8
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
8.3
8
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
8.3
8
*
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
8.3
8
*
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
8.3
8
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
8.3
8
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
8.3
8
*
1AA09
NOMESCO Finland
NA
+∞
8.3
8
*
JAH21
NOMESCO Finland
Staging laparoscopy
+∞
8.3
8
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
8.3
8
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
8.3
8
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
8.3
8
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
8.3
8
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.3
8
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
8.3
8
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
8.3
8
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
8.6
8.3
17
20
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
5.9
8.3
22
38
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
10.8
8.3
15
14
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
10.8
8.3
15
14
WX199
NOMESCO Finland
Other local analgesia
3.1
8.2
44
147
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
8.2
191
1214
L04AD01
ATC
ciclosporin; systemic
4.3
8.2
29
69
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.0
8.2
108
571
ZXC96
NOMESCO Finland
Robot assisted procedure
7.6
8.2
18
24
WX725
NOMESCO Finland
Noninvasive ventilation
2.6
8.2
59
235
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
6.1
8.2
21
35
J01CA04
ATC
amoxicillin; systemic
1.4
8.1
992
8827
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
17.3
8.1
12
7
B74
ICPC
Malignant neoplasm blood other
22.1
8.0
11
5
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
22.1
8.0
11
5
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
7.9
89
440
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
13.1
7.9
13
10
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
6.1
7.8
20
33
ZXC40
NOMESCO Finland
Use of ultrasound
8.5
7.8
16
19
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
8.5
7.8
16
19
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
10.9
7.8
14
13
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.1
7.8
40
131
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
45.2
7.7
9
*
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
45.2
7.7
9
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.2
7.7
76
355
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.2
7.7
72
331
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.6
7.7
33
94
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
18.4
7.6
11
6
ZXA05
NOMESCO Finland
Left side
1.5
7.6
333
2459
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
25.1
7.6
10
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
25.1
7.6
10
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
7.5
70
322
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
4.4
7.5
25
57
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.1
7.5
82
405
L04AA01
ATC
[U] ciclosporin; systemic
4.1
7.4
27
67
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.0
7.4
40
136
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
7.4
469
3709
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
3.4
7.3
33
98
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
7.3
7
*
L02BB04
ATC
enzalutamide; oral
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
7.3
7
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
7.3
7
*
9680/3-C49.6
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
7.3
7
*
9680/3-C49.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
7.3
7
*
9680/3-C01.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS
+∞
7.3
7
*
V03AF03
ATC
calcium folinate; systemic
+∞
7.3
7
*
390
Kela drug reimbursment
Ibrutinib
+∞
7.3
7
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
7.3
7
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
+∞
7.3
7
*
9680/3-C49.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
7.3
7
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
9680/3-C41.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
7.3
7
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
7.3
7
*
9680/3-C73.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of thyroid gland
+∞
7.3
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
7.3
7
*
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
7.3
7
*
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
7.3
7
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
7.3
7
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
7.3
7
*
9680/3-C25.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pancreas, NOS
+∞
7.3
7
*
N74
ICPC
Malignant neoplasm nervous system
+∞
7.3
7
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
7.3
7
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
7.3
7
*
C16.20
ICD-10 Finland
Malignant tumor of the corpus ventriculi without histology
+∞
7.3
7
*
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
6.9
7.3
17
25
C07AB07
ATC
bisoprolol; oral
1.4
7.3
672
5653
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
7.2
425
3311
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.0
7.2
85
432
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
15.8
7.2
11
7
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
15.8
7.2
11
7
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
15.8
7.2
11
7
RS220
NOMESCO Finland
NA
4.4
7.1
24
55
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
30.1
7.1
9
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
7.1
540
4393
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
12.1
7.1
12
10
R53
ICD-10 Finland
Malaise and fatigue
1.5
7.0
246
1729
S18
ICPC
Laceration/cut
1.4
7.0
515
4164
A02BC01
ATC
omeprazole; systemic
1.4
7.0
355
2694
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
5.9
6.9
18
31
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
7.6
6.9
15
20
KA3EB
NOMESCO Finland
Antegrade pyelography
13.8
6.9
11
8
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
13.8
6.9
11
8
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.4
6.8
31
93
C09AA05
ATC
ramipril; oral
1.4
6.8
364
2784
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
11.0
6.8
12
11
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
6.1
6.8
17
28
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
16.8
6.7
10
6
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
16.8
6.7
10
6
N05BA06
ATC
lorazepam; systemic, sublingual
2.2
6.7
67
317
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
7.2
6.7
15
21
L04AA06
ATC
mycophenolic acid; systemic
3.7
6.7
27
74
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.9
6.7
20
41
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
6.7
154
976
Z51.88
ICD-10 Finland
Other specified medical care
3.2
6.6
32
101
B03XA01
ATC
erythropoietin; parenteral
5.9
6.6
17
29
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
6.6
295
2180
EMB10
NOMESCO Finland
Tonsillectomy
2.7
6.6
43
164
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
6.6
400
3127
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
6.5
162
1045
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
10.1
6.5
12
12
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
6.5
68
328
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.2
6.5
32
103
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.5
6.5
21
47
JM2AT
NOMESCO Finland
Biopsy of spleen with ultrasound guidance
70.1
6.4
7
*
JN6CD
NOMESCO Finland
Very extensive CT of torso and neck
70.1
6.4
7
*
A21
ICPC
Risk factor for malignancy
70.1
6.4
7
*
D73.9
ICD-10 Finland
Disease of spleen, unspecified
70.1
6.4
7
*
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
70.1
6.4
7
*
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
70.1
6.4
7
*
B73
ICPC
Leukaemia
70.1
6.4
7
*
HAB99
NOMESCO Finland
Other partial excision of mammary gland
7.4
6.4
14
19
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
6.4
426
3380
G04CA02
ATC
tamsulosin; oral
1.4
6.4
332
2523
Z94.0
ICD-10 Finland
Kidney transplant status
4.9
6.4
19
39
B02
ICD-10 Finland
Zoster [herpes zoster]
2.4
6.3
51
217
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.5
6.3
17
31
KBV00
NOMESCO Finland
Insertion of stent into ureter
9.3
6.3
12
13
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
18.1
6.3
9
5
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
6.3
177
1182
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
PJ2CT
NOMESCO Finland
Biopsy of lymphnode with CT guidance
+∞
6.3
6
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
6.3
6
*
X76
ICPC
Malignant neoplasm breast female
+∞
6.3
6
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
6.3
6
*
L01AX03
ATC
temozolomide; systemic
+∞
6.3
6
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
6.3
6
*
1CA02
NOMESCO Finland
NA
+∞
6.3
6
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
6.3
6
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
6.3
6
*
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
+∞
6.3
6
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
6.3
6
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
6.3
6
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
6.3
6
*
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
+∞
6.3
6
*
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
6.3
6
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
6.3
6
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
6.3
6
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
6.3
6
*
9680/3-C06.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mouth, NOS
+∞
6.3
6
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
6.3
6
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
6.3
6
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
6.3
6
*
C16.30
ICD-10 Finland
Malignant tumor of the antrum ventriculi without histology
+∞
6.3
6
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
EBA10
NOMESCO Finland
Surgical removal of tooth
1.8
6.2
104
600
KA3GB
NOMESCO Finland
Retrograde pyelography
26.8
6.2
8
*
Z94.4
ICD-10 Finland
Liver transplant status
26.8
6.2
8
*
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
4.8
6.2
19
40
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
5.8
6.1
16
28
R18
ICD-10 Finland
Ascites
4.0
6.1
22
55
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
8.6
6.1
12
14
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
10.1
6.0
11
11
A28
ICPC
Limited function/disability NOS
1.5
6.0
200
1387
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026493) Urate [Moles/volume] in Serum or Plasma
1024
3385
7.06
314.18
6.7
2.5
umol/l
1003.1
6554.3
6.91
986
2880
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
343
17
259.39
307.65
1.3
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
342
169
25.74
307.65
1.6
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
341
84
51.88
307.65
1.5
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
237
46
60.73
307.65
2.1
2.3
%
14.8
13.7
0.23
102
23
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1079
1294
25.59
307.65
8.1
2.8
u/l
304.4
237.8
9.23
1049
1204
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
261
123
25.35
307.65
3.1
2.3
u/ml
9209.4
372.5
1.47
24
15
(3011412) CD3 cells [#/volume] in Blood
289
65
54.52
307.65
2.4
2.0
e9/l
1.0
1.2
0.62
206
32
(3017143) Hepatitis C virus Ab [Presence] in Serum
764
916
15.59
307.65
1.5
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
523
789
9.53
307.65
4.2
2.1
g/l
8.3
10.9
30.64
503
719
(46235355) HIV 1 and 2 tests - Meaningful Use set
812
1220
12.98
307.65
1.5
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
774
988
14.76
307.65
1.5
1.5
—
—
—
0
0
(4035726)
645
355
30.57
307.65
1.7
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
236
42
66.19
307.65
2.2
2.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
368
26
185.74
307.65
1.4
1.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
290
170
20.79
307.65
5.8
4.4
iu/ml
5579.5
567.9
0.48
43
20
(21494815) CD4 cells/100 lymphocytes in Specimen
205
49
48.12
307.65
2.3
1.9
%
31.2
49.4
—
17
8
(3021879) Hepatitis B virus core Ab [Presence] in Serum
689
544
22.13
307.65
1.4
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
183
53
39.06
294.50
2.5
1.6
e6/l
496.1
510.7
0.06
153
46
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
176
52
38.09
281.48
2.5
1.6
e9/l
0.2
0.2
0.19
153
46
(42870588) Differential panel, method unspecified - Blood
1058
3979
6.32
268.68
10.4
5.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1231
5332
7.56
264.44
10.8
5.5
%
0.7
0.7
0.58
1204
4900
(3019069) Monocytes/100 leukocytes in Blood
1242
5504
7.53
257.30
11.5
5.8
%
9.9
8.9
16.20
1215
5070
(3006504) Eosinophils/100 leukocytes in Blood
1236
5482
7.39
254.85
11.0
5.5
%
2.6
3.0
5.21
1209
5027
(3001604) Monocytes [#/volume] in Blood
1281
5900
8.01
252.10
10.2
5.3
e9/l
0.6
0.6
0.06
1190
5025
(3006315) Basophils [#/volume] in Blood
1283
5938
8.00
250.44
10.2
5.3
e9/l
0.0
0.0
13.28
1192
5067
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
235
186
14.73
248.07
1.4
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1241
5606
7.29
247.86
11.4
5.6
%
24.7
26.9
8.53
1215
5134
(3017181) Myelocytes/100 leukocytes in Blood
477
943
6.88
245.41
5.9
3.7
%
1.5
0.7
4.89
302
213
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1273
5926
7.66
244.30
16.2
3.9
umol/l
9.9
12.3
16.92
1252
5523
(3019198) Lymphocytes [#/volume] in Blood
1284
6034
7.83
243.46
10.4
5.4
e9/l
1.6
1.8
8.08
1204
5231
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
157
52
33.51
242.28
2.9
1.4
e6/l
418.8
837.8
2.86
63
26
(3013115) Eosinophils [#/volume] in Blood
1292
6132
7.92
241.39
11.1
5.5
e9/l
0.2
0.2
18.32
1206
5320
(3018010) Neutrophils/100 leukocytes in Blood
1217
5555
6.71
235.19
10.1
5.5
%
58.2
57.9
0.24
1192
5118
(3013650) Neutrophils [#/volume] in Blood by Automated count
1322
6543
8.27
231.26
27.6
6.3
e9/l
3.6
4.4
33.60
1249
5622
(21494814) CD8 cells/100 lymphocytes in Specimen
126
20
68.53
230.25
2.0
2.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
647
1786
5.53
229.78
8.4
2.5
mmol/l
0.8
0.8
9.09
627
1631
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
118
13
98.23
226.98
2.1
3.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
210
162
14.85
224.50
1.4
1.4
u/ml
115.7
114.6
0.05
54
23
(3028026) IgM [Mass/volume] in Serum or Plasma
374
635
7.46
221.46
3.4
1.4
g/l
1.2
1.2
0.14
353
575
(3004809) Band form neutrophils/100 leukocytes in Blood
198
141
15.97
221.34
4.6
3.0
%
1.9
1.7
0.15
167
102
(40765096) Chromosome analysis panel by Banding
115
20
62.07
206.62
1.3
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
232
243
11.07
203.42
2.4
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
227
231
11.36
203.09
2.4
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
136
52
28.59
199.73
3.6
2.2
%
33.9
42.7
2.06
63
24
(3024561) Albumin [Mass/volume] in Serum or Plasma
1116
5178
5.21
197.81
9.8
3.7
g/l
33.1
35.4
29.60
1079
4756
(3002179) Metamyelocytes/100 leukocytes in Blood
410
868
6.08
192.91
5.6
3.6
%
1.0
0.6
1.98
202
155
(3021440) Promyelocytes/100 leukocytes in Blood
418
905
5.97
191.91
6.0
3.8
%
0.2
0.1
5.49
275
193
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
187
168
12.53
181.38
2.4
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
849
3452
4.26
173.00
9.1
4.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
532
1560
4.68
168.51
3.1
2.1
%
1.8
1.8
0.04
500
1356
(3023520) Reticulocytes [#/volume] in Blood
447
1174
4.96
161.95
3.4
2.2
e9/l
69.3
70.0
0.14
388
912
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
174
182
10.65
151.70
1.4
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
165
160
11.43
151.64
1.3
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
197
247
9.00
149.67
1.4
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
80
12
70.27
146.82
1.3
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
513
1617
4.26
144.99
8.1
4.9
mmol/l
1.0
1.0
0.30
495
1479
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
353
840
5.16
142.63
2.4
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
317
693
5.50
141.17
2.0
1.4
ug/l
7.4
3.6
0.60
219
522
(3044640) Blood type and Crossmatch panel - Blood
785
3366
3.72
140.54
4.3
2.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
164
181
10.02
137.24
2.0
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
353
866
4.99
137.17
5.8
3.9
%
0.1
0.6
0.46
211
169
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1126
6249
3.99
132.27
14.2
5.4
mmol/l
1.2
1.2
2.88
938
5257
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
156
169
10.16
132.26
1.3
1.2
u/ml
284.0
279.7
0.04
111
97
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
146
146
10.94
131.05
2.2
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
113
76
15.97
129.22
1.7
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1052
5665
3.71
127.57
12.6
5.0
mmol/l
1.2
1.2
1.34
1012
4996
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
89
36
26.18
127.48
4.8
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
994
5174
3.60
127.04
7.5
3.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
832
3943
3.42
122.55
7.9
2.0
mmol/l
2.3
2.4
1.48
777
3245
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
191
293
7.30
121.41
1.4
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
351
949
4.50
119.63
1.7
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
138
145
10.36
119.43
1.9
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
124
112
11.95
119.04
2.2
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
790
3709
3.32
116.65
2.5
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
116
105
11.87
111.11
2.3
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
131
142
9.99
110.71
2.0
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
118
111
11.43
110.17
5.0
3.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
593
2423
3.36
108.87
9.7
4.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
110
97
12.14
107.11
2.3
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
134
160
9.08
105.13
2.0
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
211
413
5.76
104.82
2.3
3.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
360
1097
3.98
103.16
2.2
1.6
g/l
62.7
66.9
14.43
341
982
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
151
217
7.61
101.42
1.6
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
747
3612
3.08
101.03
9.5
3.2
ph
7.4
7.4
1.57
194
620
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
558
2297
3.24
99.72
5.4
2.2
mmol/l
2.5
2.5
6.25
537
1960
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
100
85
12.51
99.59
1.4
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1350
9294
4.70
98.49
21.4
5.4
u/l
84.5
77.2
7.09
1326
8556
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
598
2620
3.10
95.18
4.2
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
614
2755
3.05
93.33
22.1
4.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
59
20
30.64
89.40
1.2
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
517
2149
3.12
89.32
3.0
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
63
26
25.22
89.26
3.1
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
935
5375
2.89
87.88
11.1
10.6
inr
1.2
1.4
3.99
251
1510
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
155
267
6.34
87.52
1.6
1.2
e6/l
18.5
38.8
0.44
136
219
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
155
267
6.34
87.52
1.7
1.3
e6/l
847.1
964.8
0.06
138
227
(3044290) Cell count panel - Cerebral spinal fluid
144
232
6.74
86.80
1.5
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
98
102
10.19
85.03
4.2
3.0
%
57.5
55.9
0.18
63
66
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
85
74
12.10
83.23
2.6
2.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
84
73
12.11
82.34
1.3
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
64
34
19.60
81.75
1.5
1.0
—
—
—
0
0
(44790048)
101
120
8.94
79.26
1.9
1.3
—
—
—
0
0
(44790049)
101
120
8.94
79.26
1.9
1.3
—
—
—
0
0
(44790047)
101
120
8.94
79.26
1.9
1.4
—
—
—
0
0
(44806118)
101
120
8.94
79.26
1.9
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
211
529
4.46
77.54
2.6
1.7
ug/l
3.9
1.7
0.79
192
464
(3021589) Normoblasts [#/volume] in Blood
889
5224
2.66
75.89
19.8
8.7
e9/l
0.0
0.0
0.96
771
4250
(3033658) Prothrombin time (PT) actual/Normal
585
2853
2.70
72.30
6.0
3.5
%
85.4
85.1
0.11
573
2776
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
71
58
12.79
72.25
2.3
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
71
58
12.79
72.25
2.3
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1286
9264
3.37
71.85
7.5
4.2
mm/h
17.6
12.7
17.63
1240
8492
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
75
68
11.54
71.44
2.2
1.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
60
38
16.39
70.37
1.8
2.3
u/ml
7156.0
6647.8
—
8
5
(3007164) IgA [Mass/volume] in Serum or Plasma
463
2031
2.83
70.04
2.9
1.3
g/l
2.0
2.7
12.14
387
1149
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
136
257
5.71
69.48
1.9
1.9
u/ml
325.8
119.8
0.74
96
203
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
80
84
9.99
68.84
2.5
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
80
86
9.76
67.66
2.6
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
80
86
9.76
67.66
2.6
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
80
86
9.76
67.66
2.6
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
452
1995
2.79
67.20
3.0
1.9
s
29.2
29.9
1.66
439
1926
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
137
271
5.45
66.55
1.6
1.2
mmol/l
3.8
3.9
0.57
129
249
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
373
1509
2.94
65.06
2.9
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
372
1515
2.92
63.99
2.7
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
262
872
3.42
63.65
1.3
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
398
1708
2.79
61.82
2.1
2.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
38
10
38.94
61.60
1.3
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
100
158
6.70
61.13
6.2
6.6
mg/l
11.6
12.0
0.37
89
145
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
51
31
16.98
60.98
2.9
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
121
236
5.48
59.60
1.3
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
97
153
6.70
59.37
2.0
2.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1084
7473
2.53
59.33
9.1
4.3
mmol/l
6.7
6.9
1.59
1057
6990
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
50
31
16.64
59.18
2.9
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
50
31
16.64
59.18
2.9
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
109
196
5.91
58.55
7.9
3.2
%
58.5
58.5
0.00
109
196
(3016018) Differential panel - Cerebral spinal fluid
82
111
7.75
57.63
1.4
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
158
397
4.32
57.39
3.4
2.9
u/ml
0.4
0.3
0.13
99
235
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
55
43
13.23
57.36
2.9
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
55
43
13.23
57.36
2.9
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
55
43
13.23
57.36
2.9
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
55
43
13.23
57.36
2.9
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
142
332
4.61
56.53
1.6
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
152
377
4.36
56.13
1.6
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
105
191
5.83
55.69
5.6
3.1
e9/l
3.6
4.4
2.64
105
191
(3031040) Bacteria [#/volume] in Urine by Automated count
1121
8079
2.43
51.83
5.9
4.5
e6/l
2061.6
2023.0
0.01
21
126
(3030467) Casts [#/volume] in Urine by Automated count
606
3424
2.27
50.22
4.1
3.0
e6/l
0.5
0.4
0.28
497
2586
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
52
46
11.66
50.19
1.3
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
58
61
9.84
49.73
1.4
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
532
2869
2.31
49.06
1.6
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
294
1205
2.78
48.81
4.2
2.4
umol/l
8.6
8.4
0.06
260
1044
(3002582) Erythrocytes [#/volume] in Urine
637
3728
2.21
47.87
4.3
3.1
e6/l
47.8
92.3
1.09
530
2862
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
74
110
7.02
47.80
1.3
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
35
16
22.36
47.35
2.0
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
581
3290
2.23
47.25
4.1
3.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
93
176
5.56
47.22
1.3
1.2
miu/ml
175.4
184.8
0.05
13
68
(21494434) Karyotype in Bone marrow
70
103
7.07
45.62
1.2
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
700
4366
2.11
43.52
4.0
3.1
ng/l
2019.5
1482.9
2.32
648
3728
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
70
109
6.68
43.28
4.0
2.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
208
761
3.00
42.25
1.8
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
52
59
9.09
42.09
4.0
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
692
4361
2.07
41.19
5.0
3.5
e6/l
183.5
114.1
0.35
553
3098
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
150
457
3.53
41.17
1.7
1.4
g/l
0.7
0.4
0.73
134
390
(3020779) Urea [Moles/volume] in Serum or Plasma
265
1117
2.66
41.16
9.8
6.3
mmol/l
10.1
10.9
0.90
258
1054
(40768806) Pleura Pathology biopsy report
61
87
7.26
40.87
1.6
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
166
542
3.31
40.85
1.9
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
166
542
3.31
40.85
1.9
1.4
g/l
3.7
3.9
0.69
128
392
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
166
542
3.31
40.85
1.9
1.4
g/l
7.7
7.5
0.48
127
406
(3026782) Osmolality of Urine
450
2416
2.22
40.64
3.5
2.6
mosm/kgh2o
538.0
547.8
0.47
409
2021
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
137
403
3.63
39.63
1.7
1.3
g/l
0.1
0.0
0.43
131
370
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
175
609
3.11
38.67
1.5
1.6
g/l
1.8
1.5
2.57
140
520
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
155
505
3.30
38.21
2.0
1.4
g/l
3.7
3.1
5.67
128
399
(3025941) Bacteria identified in Stool by Culture
168
583
3.11
37.26
1.4
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
337
1667
2.31
36.63
2.5
2.6
%
21.7
23.0
0.76
298
1395
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
236
992
2.63
36.60
12.5
3.0
mmol/l
1.2
1.2
0.99
230
828
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
613
3834
2.00
35.96
2.9
2.3
u/l
50.8
58.3
2.52
558
3486
(3000850) Epithelial cells [#/volume] in Urine
464
2628
2.10
35.80
3.4
2.4
e6/l
3.8
5.0
3.21
426
2279
(3022948) Iron [Moles/volume] in Serum or Plasma
373
1946
2.21
35.52
2.5
2.4
umol/l
11.8
12.9
2.23
346
1777
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
151
512
3.16
34.77
1.7
1.4
g/l
8.9
10.5
4.48
138
430
(3019832) Treponema pallidum Ab [Presence] in Serum
138
445
3.31
34.52
1.4
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
348
1789
2.22
34.23
2.5
2.5
g/l
2.1
2.3
8.30
325
1648
(3028433) Virus identified in Specimen by Culture
38
38
10.23
33.69
1.3
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
124
381
3.45
33.47
1.7
1.3
g/l
0.0
0.0
0.50
118
349
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
123
376
3.47
33.47
1.7
1.3
g/l
0.0
0.0
0.00
118
348
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
128
407
3.34
32.72
2.0
1.5
mg/l
32.8
48.4
0.56
98
329
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
225
975
2.53
32.57
2.4
1.9
g/l
0.2
0.2
1.64
206
878
(40758292) HTLV I+II Ab panel - Serum
37
6
63.12
32.15
1.5
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
127
408
3.30
31.92
2.0
1.5
mg/l
60.1
45.7
0.61
98
330
(3001964) Herpes simplex virus Ag [Presence] in Specimen
33
29
11.61
31.87
1.6
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
124
393
3.34
31.86
2.0
1.4
ratio
17.1
1.3
—
10
33
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
525
3227
1.95
31.44
2.1
2.3
mg/l
3.5
3.0
3.56
450
2703
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
131
434
3.21
31.30
1.7
1.3
g/l
34.4
37.5
5.15
122
365
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
104
298
3.67
31.19
1.8
2.0
mg/l
10.9
12.0
0.74
98
269
(3012441) Differential panel - Pleural fluid
58
104
5.76
31.13
1.7
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
61
116
5.43
30.75
1.5
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
27
18
15.25
30.57
1.7
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
563
3569
1.91
30.55
6.8
2.6
u/l
34.4
41.8
0.79
537
3376
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
196
823
2.58
30.20
6.3
3.5
mmol/l
2.1
1.8
0.48
167
586
(3009343) pH of Capillary blood
200
855
2.54
29.66
6.2
3.5
ph
7.4
7.4
1.51
18
106
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
41
54
7.77
29.40
1.5
1.2
%
65.5
56.6
—
11
7
(3026008) Bacteria identified in Urine by Culture
589
3829
1.87
29.26
3.7
3.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
201
870
2.51
29.02
6.2
3.5
kpa
5.0
5.2
1.73
191
795
(3000991) Gas panel - Venous blood
228
1046
2.39
28.97
9.0
6.9
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
25
16
15.87
28.87
1.6
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
29
25
11.80
28.32
1.8
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
262
1291
2.24
28.12
7.4
3.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
69
160
4.47
27.59
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
275
1394
2.18
27.47
1.9
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
98
294
3.49
27.40
2.2
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
742
5258
1.79
27.22
4.9
4.0
ng/l
51.0
62.4
0.21
643
3909
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
348
1935
2.03
27.20
3.9
2.9
e6/l
1.9
2.5
0.73
220
1058
(3037467) Urinalysis macro (dipstick) panel - Urine
1073
8517
1.86
26.61
5.7
4.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
57
117
5.02
26.39
1.5
1.6
u/ml
3.2
41.9
0.60
57
112
(3000093) Morphology [Interpretation] in Blood Narrative
56
115
5.02
25.91
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
49
92
5.47
25.05
1.2
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
217
1036
2.27
24.96
2.0
1.7
nmol/l
373.5
361.4
0.41
208
922
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
61
139
4.53
24.93
1.4
1.8
u/ml
23.9
45.2
0.63
55
126
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
363
2110
1.94
24.71
3.6
2.7
e6/l
1.0
1.4
0.90
234
1228
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1387
12152
2.44
24.67
42.9
13.8
mg/l
25.7
24.8
0.55
1308
9514
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
29
6
49.19
24.33
1.6
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
287
1563
2.03
23.43
9.7
5.6
mmol/l
103.9
104.2
0.31
277
1517
(3022313) Gas panel - Capillary blood
151
631
2.54
23.32
7.2
3.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
52
110
4.86
23.25
1.1
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
246
1272
2.11
23.08
6.4
3.2
mmol/l
1.8
2.0
0.42
201
1016
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
204
984
2.24
22.80
2.2
2.3
u/l
33.8
38.9
0.43
178
813
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
409
2531
1.84
22.68
2.0
1.7
mg/l
1.9
1.3
1.25
325
1963
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
127
499
2.68
22.20
1.8
1.9
u/l
43.3
39.1
1.02
112
421
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
132
535
2.61
21.68
7.8
3.8
mmol/l
25.6
24.6
3.12
126
491
(3021447) Carbon dioxide [Partial pressure] in Venous blood
241
1278
2.05
21.01
6.6
3.1
kpa
5.7
5.8
1.98
234
1231
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
57
141
4.16
20.99
2.2
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
45
92
5.01
20.94
1.3
1.8
u/l
0.9
2521.3
—
10
29
(3025468) Yersinia sp identified in Specimen by Organism specific culture
57
142
4.13
20.79
2.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
130
534
2.57
20.77
3.0
1.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
87
288
3.14
20.76
3.8
2.1
%
87.7
88.9
0.17
87
274
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
78
242
3.34
20.69
1.5
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
62
165
3.87
20.67
1.0
1.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
55
134
4.22
20.66
1.7
1.5
e6/l
2165.3
1839.4
0.25
42
95
(3003396) Base excess in Arterial blood by calculation
268
1485
1.97
20.63
10.4
6.3
mmol/l
1.3
1.3
0.04
209
1137
(3005988) Vibrio sp identified in Specimen by Organism specific culture
57
143
4.10
20.60
2.2
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
82
264
3.22
20.49
2.0
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
81
259
3.25
20.47
5.4
4.4
mmol/l
2.8
2.8
0.02
66
174
(3010375) cycloSPORINE [Mass/volume] in Blood
30
42
7.27
20.39
33.8
24.1
ug/l
106.0
127.6
0.83
25
37
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
57
146
4.02
20.04
2.2
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
420
2708
1.76
19.89
4.6
4.0
ng/l
721.7
479.6
0.23
370
2280
(3028308) Erythrocytes [#/volume] in Pleural fluid
51
121
4.33
19.83
1.5
1.5
e6/l
34054.4
89043.1
0.48
31
68
(3027801) Oxygen [Partial pressure] in Arterial blood
266
1489
1.95
19.82
10.3
6.3
kpa
12.2
11.4
1.91
252
1422
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
266
1489
1.95
19.82
10.3
6.3
kpa
4.9
5.1
1.60
249
1424
(3000012) Reticulocyte production index
39
74
5.38
19.72
1.5
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
57
148
3.96
19.67
2.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
57
149
3.93
19.49
2.2
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
211
1097
2.07
19.33
8.1
5.8
mmol/l
1.7
1.5
1.49
201
1058
(3016502) Oxygen saturation in Arterial blood
244
1343
1.97
19.05
11.0
6.5
%
96.1
95.0
3.09
233
1293
(3019225) pH of Specimen
237
1297
1.98
18.80
8.5
3.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32
53
6.14
18.61
1.1
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
18
14
13.00
18.57
1.5
1.1
u/ml
27.3
19.5
0.58
18
14
(3019060) Gas panel - Arterial blood
181
902
2.14
18.50
9.1
4.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
36
69
5.32
18.01
1.6
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
50
127
4.04
17.79
1.3
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
30
49
6.22
17.69
1.7
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
30
49
6.22
17.69
1.7
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
78
268
3.01
17.48
4.0
3.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
80
280
2.96
17.36
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
80
280
2.96
17.36
1.4
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
57
5.71
17.30
1.0
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
223
1228
1.95
17.30
11.8
6.7
g/l
110.3
122.5
13.23
213
1187
(3010421) pH of Blood
86
314
2.84
17.28
5.5
4.1
ph
7.4
7.4
4.43
80
257
(3007853) Bacteria identified in Skin by Aerobe culture
248
1416
1.90
17.26
1.9
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
183
954
2.04
16.55
4.9
3.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
34
67
5.17
16.51
1.6
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
61
188
3.34
16.38
1.8
2.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
641
4801
1.57
16.15
3.0
2.8
ug/l
493.0
141.8
10.26
586
4346
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
16
13
12.43
16.04
1.2
1.6
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
21
27
7.87
15.31
1.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
19
22
8.73
15.03
4.2
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
70
250
2.89
14.67
4.0
2.2
%
233.0
198.2
1.82
65
236
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
111
498
2.32
14.61
2.2
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
59
5.17
14.61
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
22
32
6.96
14.44
1.0
1.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
70
258
2.79
13.85
1.6
2.7
umol/l
31.9
38.0
0.69
59
220
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
15
14
10.81
13.76
1.2
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
892
7339
1.51
13.74
4.4
3.0
u/l
70.5
51.4
3.60
824
6664
(3024932) HLA-DR beta [Type]
21
31
6.85
13.60
1.3
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
265
1654
1.73
13.51
1.3
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
648
5014
1.51
13.28
2.5
2.2
nmol/l
76.5
78.5
1.07
594
4355
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
23
7.91
13.17
1.1
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
20
29
6.97
13.15
1.9
1.4
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
15
15
10.09
13.14
1.1
1.1
mmol/l
2.3
0.9
—
10
6
(3017732) Neutrophils [#/volume] in Blood
150
790
2.00
13.12
2.5
3.1
e9/l
3.7
4.2
2.01
107
556
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
126
624
2.11
13.02
8.5
3.6
mmol/l
24.2
24.3
0.20
116
552
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
68
261
2.68
12.48
1.3
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
160
878
1.92
12.41
12.7
6.4
mmol/l
24.8
24.5
0.42
149
822
(3052592) Norovirus Ag [Presence] in Stool
17
22
7.80
12.30
1.9
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
28
61
4.66
12.14
1.3
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
84
363
2.39
12.05
4.5
3.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
56
198
2.90
11.99
1.4
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
25
50
5.07
11.96
1.2
1.1
ng/l
2930.8
54.0
0.99
13
11
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
18
26
6.99
11.87
1.3
1.1
ug/l
1.5
1.3
—
11
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
10
12.09
11.75
1.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
12
10
12.09
11.75
1.0
1.2
%
107.4
94.6
—
12
10
(40757373) Influenza virus identified in Isolate
20
33
6.13
11.67
1.6
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
16
7
23.08
11.57
5.5
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
30
72
4.23
11.55
1.2
1.1
mg/l
93.3
34.3
2.13
22
65
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
27
60
4.56
11.44
1.1
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
27
60
4.56
11.44
1.1
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
21
7.69
11.43
1.1
1.0
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
38
110
3.52
11.30
1.4
1.2
g/l
0.3
0.4
1.05
25
81
(3027135) IgG subclass 1 [Mass/volume] in Serum
38
110
3.52
11.30
1.4
1.2
g/l
4.8
7.0
2.66
26
82
(4062490)
38
110
3.52
11.30
1.5
1.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
38
110
3.52
11.30
1.4
1.2
g/l
1.8
2.9
2.46
26
81
(3035880) pH of Pleural fluid
27
61
4.49
11.22
1.5
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
25
53
4.78
11.20
5.7
3.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
558
4301
1.47
11.11
2.4
2.2
u/l
172.4
241.7
1.04
525
4026
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
24
50
4.86
10.97
2.4
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1115
9819
1.49
10.80
46.2
16.5
%
14.7
13.7
67.11
1102
9554
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
223
1409
1.68
10.73
1.3
1.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
15
7
21.62
10.68
1.0
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
191
1159
1.74
10.65
1.3
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
141
781
1.89
10.62
10.0
7.8
%
94.4
93.2
3.12
141
776
(3045788) Cell count panel - Pleural fluid
37
110
3.42
10.58
1.5
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
78
348
2.31
10.44
1.6
1.6
iu/ml
0.1
0.1
0.69
19
77
(3013512) EKG study
518
3976
1.46
10.38
5.4
4.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
48
170
2.88
10.28
1.6
1.8
g/l
0.6
1.0
1.92
35
133
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
122
653
1.94
10.18
16.9
9.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
109
576
1.96
9.45
2.8
3.1
pmol/l
4.3
4.5
1.42
95
490
(3024891) Influenza virus A+B Ag [Presence] in Specimen
64
277
2.37
9.21
1.3
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
206
1326
1.64
9.17
4.1
3.1
ng/l
276.2
222.4
0.95
195
1229
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
167
1018
1.72
9.13
4.5
3.6
ng/l
85.7
91.9
0.38
140
868
(4027681)
23
55
4.23
8.93
1.4
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
46
173
2.71
8.85
1.6
1.3
iu/l
28.5
27.0
0.10
41
149
(3019550) Sodium [Moles/volume] in Serum or Plasma
1390
13013
1.71
8.77
42.3
16.6
mmol/l
139.2
139.8
13.71
1370
12626
(40767503) Oxygen content in Capillary blood by calculation
62
271
2.34
8.74
3.4
2.4
%
14.4
16.7
3.10
29
146
(3044889) 12 lead EKG panel
1020
8985
1.40
8.66
5.4
4.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
13
8
16.38
8.55
1.8
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
279
1964
1.51
8.39
26.4
29.3
inr
1.4
1.4
0.06
39
278
(3010937) Rubella virus Ab [Presence] in Serum
8
0
+∞
8.34
1.1
0.0
—
—
—
0
0
(3020891) Body temperature
103
558
1.91
8.32
6.1
4.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
22
54
4.12
8.27
1.0
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1390
13051
1.68
8.18
42.9
16.7
mmol/l
4.0
4.0
0.27
1368
12644
(40768793) Breast Pathology biopsy report
26
73
3.61
8.14
1.3
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
113
636
1.84
8.11
9.6
8.1
mmol/l
24.1
24.4
0.49
106
582
(3035637) Corticotropin [Mass/volume] in Plasma
29
88
3.34
8.09
1.3
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
13
20
6.55
8.07
1.7
2.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1258
11561
1.48
8.05
35.1
12.7
ml/min/173m2
76.3
75.5
0.75
1159
9274
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
25
69
3.67
8.02
1.1
1.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
169
1071
1.65
7.98
6.5
2.6
kpa
4.9
4.5
0.98
162
1028
(3051611) Lipemic interference index of Serum or Plasma
34
115
3.00
7.95
4.9
3.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
71
342
2.13
7.95
1.4
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
716
6006
1.36
7.94
6.2
5.0
estimate
0.0
0.0
0.00
200
1061
(3035350) Ketones [Presence] in Urine by Test strip
715
6000
1.36
7.89
4.7
3.7
estimate
0.0
0.0
0.00
196
1055
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
45
178
2.57
7.87
1.2
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
14
24
5.88
7.86
1.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
73
358
2.09
7.81
3.2
3.1
mmol/l
23.9
25.0
1.18
64
313
(3047181) Lactate [Moles/volume] in Blood
82
420
2.01
7.80
15.2
5.7
mmol/l
1.5
1.3
1.50
71
375
(3029937) Albumin [Presence] in Urine by Test strip
428
3312
1.40
7.77
5.3
4.1
estimate
0.0
0.0
0.50
181
1018
(3014765) Yersinia sp identified in Stool by Organism specific culture
71
346
2.10
7.72
1.4
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
19
44
4.36
7.69
1.1
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
71
348
2.09
7.61
1.4
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
86
453
1.95
7.56
2.7
1.9
—
—
—
0
0
(3048879) Bone marrow aspiration report
16
33
4.89
7.41
1.5
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
17
37
4.63
7.41
1.1
1.1
miu/ml
1087.8
1543.0
0.83
17
37
(3009261) Glucose [Presence] in Urine by Test strip
719
6080
1.34
7.36
4.8
3.8
estimate
0.0
0.0
0.80
188
1021
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
7
0
+∞
7.30
1.0
0.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
16
34
4.74
7.17
2.5
2.6
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
10
5
20.12
7.13
1.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
258
3506
0.68
7.13
1.7
1.6
mmol/l
1.5
1.4
2.26
211
2896
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
30
101
3.01
7.10
1.1
1.1
u/l
75.8
52.0
0.52
24
71
(3009542) Hematocrit [Volume Fraction] of Blood
1169
10681
1.39
7.00
36.9
15.3
%
36.5
39.4
17.65
711
6850
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
35
4.61
6.94
1.1
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
11
8
13.84
6.89
1.1
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
26
82
3.21
6.86
1.2
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
89
492
1.86
6.79
1.4
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
34
126
2.74
6.79
1.4
1.4
mosm/kgh2o
271.4
276.3
0.62
27
92
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
69
352
2.01
6.68
1.2
1.3
—
17.9
—
0
9
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
30
105
2.89
6.65
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
21
59
3.59
6.60
1.2
1.0
u/l
1.2
1.1
—
10
32
(3026389) Candida sp identified in Specimen by Organism specific culture
36
140
2.61
6.56
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1383
13086
1.56
6.48
25.2
9.4
u/l
26.8
25.9
0.97
1362
12476
(3021901) Oxygen saturation in Capillary blood
54
254
2.17
6.47
3.0
2.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1149
12338
0.73
6.46
4.4
4.8
mmol/l
4.4
4.5
3.34
1032
11255
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
28
96
2.95
6.44
1.1
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
34
130
2.65
6.41
1.2
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1138
12230
0.73
6.34
4.3
4.8
mmol/l
1.3
1.4
11.33
1011
11070
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
45
198
2.31
6.32
3.9
3.3
—
—
—
0
0
(40758358) Immune stain study
6
0
+∞
6.25
1.0
0.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
28
99
2.86
6.11
1.2
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
15
35
4.32
6.03
1.9
1.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
77
423
1.86
6.02
2.9
2.5
g/l
0.9
0.3
0.60
41
138
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
55
270
2.08
5.93
1.2
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1338
12615
1.47
5.92
32.5
13.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
77
426
1.85
5.90
5.5
3.9
mmol/l
3.8
3.9
0.85
70
396
(3018572) Chloride [Moles/volume] in Blood
58
296
2.00
5.65
19.7
6.3
mmol/l
104.4
105.4
0.59
50
271
(3039000) Anion gap in Blood
58
296
2.00
5.65
19.7
6.3
mmol/l
10.8
11.0
0.16
50
271
(3021960) Folate [Moles/volume] in Serum or Plasma
413
3321
1.33
5.61
1.5
1.5
nmol/l
19.6
20.4
0.48
348
2756
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
35
146
2.43
5.57
3.8
3.7
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
62
328
1.93
5.46
1.4
1.6
g/l
0.2
0.2
0.05
57
317
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
128
834
1.58
5.43
2.1
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
39
174
2.27
5.35
1.2
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
58
303
1.95
5.31
2.6
2.0
g/l
118.7
132.9
2.89
41
227
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1191
12635
0.75
5.22
4.8
5.4
mmol/l
2.6
2.6
2.10
1053
11470
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
0
+∞
5.21
1.4
0.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1376
13102
1.48
5.20
45.6
16.0
umol/l
84.8
81.3
1.90
1376
13097
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
93
567
1.68
5.15
13.4
4.4
%
1.6
1.7
0.62
84
540
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
104
653
1.64
5.14
4.5
3.3
%
51.1
48.1
0.63
104
641
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
714
0.45
5.13
1.8
1.8
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
92
560
1.68
5.12
13.8
4.5
%
0.9
0.9
0.07
84
534
(3019309) Folate [Moles/volume] in Red Blood Cells
350
2782
1.33
5.09
1.8
1.8
nmol/l
1233.4
1168.9
0.53
268
2076
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
32
134
2.42
5.07
1.2
1.2
u/ml
3.7
7.1
0.87
14
67
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
18
55
3.30
5.03
3.0
4.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
18
56
3.24
4.90
1.2
1.1
u/l
31.5
19.0
0.53
18
48
(3017446) Testosterone [Moles/volume] in Serum or Plasma
119
782
1.57
4.88
2.4
2.2
nmol/l
12.3
14.8
2.76
111
677
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
28
114
2.48
4.72
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
79
474
1.70
4.66
1.1
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
52
275
1.92
4.63
1.1
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
22
80
2.78
4.62
2.6
2.0
min
517.8
498.0
—
9
58
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
45
227
2.01
4.58
1.1
1.5
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
5
14.05
4.58
1.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
11
8.22
4.56
1.0
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
542
4632
1.26
4.44
5.1
4.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
375
3064
1.30
4.40
4.5
3.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
46
238
1.96
4.38
1.7
1.3
mmol/l
64.9
65.0
0.01
39
191
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
18
61
2.97
4.29
1.2
1.1
u/l
302.7
86.6
0.52
18
53
(3042733) HLA Ab [Presence] in Serum
12
31
3.89
4.26
5.6
4.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
204
1532
1.38
4.25
1.3
1.3
titre
795.5
561.1
0.53
44
357
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
36
3.63
4.21
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
36
3.63
4.21
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
31
141
2.22
4.13
1.2
1.2
u/ml
5.0
3.9
—
7
47
(3027456) Digoxin [Moles/volume] in Serum or Plasma
57
324
1.79
4.09
3.0
3.2
nmol/l
1.0
0.8
0.83
40
250
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
16
52
3.10
4.09
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
12
32
3.77
4.09
3.0
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1114
11823
0.79
3.99
4.1
4.3
mmol/l
1.4
1.3
2.30
993
10599
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
14
6.46
3.98
1.6
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
11
7.30
3.86
1.8
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
11
7.30
3.86
1.8
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
11
7.30
3.86
1.7
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
20
77
2.62
3.81
3.7
2.3
ph
7.4
7.4
—
8
26
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
18
66
2.75
3.76
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
50
3.02
3.69
1.1
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
26
116
2.26
3.65
2.8
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
13
6.18
3.50
1.7
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
140
1021
1.41
3.48
3.3
2.4
ml/min/173m2
57.3
63.2
0.78
51
420
(4281824)
15
53
2.85
3.36
1.1
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
14
5.74
3.34
5.6
5.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
53
315
1.71
3.32
2.0
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
14
48
2.93
3.30
1.1
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
7
8.60
3.26
1.0
1.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
1399
13538
1.37
3.13
56.5
20.1
fl
92.2
91.5
6.61
1382
13260
(3035941) MCH [Entitic mass]
1399
13539
1.37
3.12
56.4
20.0
pg
30.5
30.5
0.92
1382
13262
(3026361) Erythrocytes [#/volume] in Blood
1399
13540
1.37
3.11
56.7
20.1
e12/l
4.1
4.5
108.70
1365
13018
(3010813) Leukocytes [#/volume] in Blood
1399
13541
1.37
3.10
56.7
20.2
e9/l
6.4
6.8
4.24
1366
13023
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1129
11877
0.81
3.10
5.6
6.5
mmol/mol
40.7
40.8
0.16
1006
10879
(3000963) Hemoglobin [Mass/volume] in Blood
1399
13543
1.37
3.08
56.9
20.3
g/l
122.9
136.0
127.77
1381
13261
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
34
3.25
3.06
1.1
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
16
5.02
3.05
1.0
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
355
3000
1.24
3.05
1.7
1.7
pmol/l
40636524.2
31176174.8
0.09
283
2441
(3004451) EKG impression Narrative
17
68
2.52
3.04
1.4
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1398
13536
1.36
3.04
56.8
20.1
e9/l
212.9
242.4
42.17
1367
13077
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
25
481
0.51
2.89
1.4
1.5
—
—
—
0
0
(4306422)
27
137
1.99
2.81
1.3
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
18
4.46
2.79
1.7
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
18
4.46
2.79
1.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
31
3.24
2.77
1.0
1.1
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
5
6
8.36
2.75
6.2
5.8
g/mol
427.2
37.3
—
5
6
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
6
8.36
2.75
1.6
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
14
5.02
2.73
1.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
10
6.02
2.70
1.0
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
48
296
1.64
2.68
1.1
1.1
titre
87.1
83.3
—
7
27
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
11
38
2.91
2.58
1.1
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
18
81
2.24
2.54
1.1
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
39
2.83
2.47
1.1
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
7
16
4.39
2.47
8.4
1.1
—
41.3
—
0
6
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
26
138
1.90
2.42
1.2
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
23
117
1.98
2.41
2.8
2.4
ml
755.2
606.4
—
10
76
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
12
5.01
2.40
1.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
27
3.35
2.39
1.1
2.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
153
1922
0.77
2.38
1.2
1.2
u/ml
14.6
14.4
0.01
44
718
(3034770) Mitochondria Ab [Titer] in Serum
48
306
1.59
2.38
1.1
1.2
—
1898.9
—
0
9
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
40
2.76
2.37
4.0
2.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
50
322
1.57
2.37
1.7
1.5
ug/g
205.1
297.9
2.93
31
188
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
52
2.51
2.36
1.4
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
249
0.40
2.35
1.4
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
71
2.27
2.34
2.2
2.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
91
664
1.39
2.33
1.2
1.2
u/ml
317.7
252.3
0.14
80
607
(3033799) Differential panel - Peritoneal fluid
9
28
3.23
2.31
1.0
1.7
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
14
59
2.39
2.29
1.3
1.3
umol/l
4.6
5.2
—
8
33
(3047189) Immunofixation for 24 hour Urine
11
41
2.70
2.28
1.7
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
40
626
0.63
2.23
1.2
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
156
1245
1.28
2.20
2.2
2.1
ug/g
224.4
167.5
0.53
130
969
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
95
1252
0.74
2.11
1.4
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
628
5744
1.16
2.11
2.0
2.1
pmol/l
90.6
93.5
0.82
366
2901
(3045424) Erythrocytes [Presence] in Urine
31
183
1.71
2.09
1.6
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
585
5331
1.16
2.05
4.6
3.9
ug/l
3.3
2.1
0.82
515
4755
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
63
2.23
2.01
1.6
1.4
u/l
17.1
8.8
—
8
27
(40768446) Kidney Pathology biopsy report
10
38
2.64
2.01
1.3
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
30
488
0.61
2.00
1.3
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
57
2.29
1.98
1.5
1.3
—
—
—
0
0
(1002224) Polysomnography panel
22
387
0.56
1.98
1.1
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
29
172
1.70
1.94
3.0
2.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
29
173
1.69
1.90
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
77
570
1.37
1.86
1.2
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
342
3013
1.17
1.84
4.7
3.7
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
13
59
2.21
1.84
1.2
1.3
u/l
134.6
398.8
0.87
13
53
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
27
160
1.70
1.82
1.9
2.4
mg/l
27.0
22.0
—
8
35
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
29
2.77
1.79
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
165
1362
1.24
1.78
2.4
2.5
ug/l
13.8
7.8
0.72
131
1182
(4010399)
71
949
0.74
1.77
1.5
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
74
2.04
1.75
2.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
74
2.04
1.75
2.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
36
2.51
1.74
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
36
541
0.66
1.73
1.3
1.8
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
30
2.68
1.72
7.3
7.8
—
—
—
0
0
(3036603) Volume of Urine
13
61
2.14
1.71
1.5
1.3
ml
1726.8
1917.9
—
6
15
(40761535) Cells panel - Urine sediment
143
1171
1.24
1.67
4.4
3.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
19
3.17
1.66
1.3
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
21
120
1.76
1.62
1.0
1.0
u/ml
1.5
2.3
—
8
43
(4268621)
18
98
1.85
1.62
2.3
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
43
2.33
1.60
5.5
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
43
2.33
1.60
5.5
2.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
36
242
1.50
1.50
2.0
1.9
iu/l
7.8
4.3
—
10
85
(1761482) Bacteria [#/volume] in Urine by Culture
50
360
1.40
1.48
4.4
4.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
668
6245
1.12
1.47
2.8
2.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
28
2.51
1.45
1.1
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
16
3.13
1.44
1.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
16
3.13
1.44
1.6
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
16
3.13
1.44
2.2
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
426
4659
0.88
1.43
4.0
4.0
mg/mmol
7.9
7.6
0.07
279
2977
(3024928) Oxygen saturation in Venous blood
41
288
1.44
1.40
9.5
2.7
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
17
97
1.76
1.35
1.5
1.2
mmol/l
23.5
34.9
2.67
17
85
(3035320) C reactive protein [Mass/volume] in Body fluid
14
75
1.87
1.34
2.0
2.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
10
47
2.14
1.33
1.0
1.5
ug/l
5.9
10.9
—
10
39
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
221
0.54
1.33
1.2
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
113
1.69
1.32
1.3
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
966
9258
1.12
1.31
3.9
3.8
pmol/l
15.0
15.0
0.09
873
8257
(4146454)
9
175
0.51
1.29
2.7
2.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
84
1.79
1.27
2.7
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
25
2.41
1.24
1.2
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
68
532
1.29
1.21
1.8
2.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
14
78
1.80
1.21
2.2
2.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
346
3794
0.89
1.20
3.0
3.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
37
507
0.72
1.16
1.1
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
39
2.06
1.15
7.3
7.9
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
22
144
1.54
1.09
1.0
1.0
g/l
1.8
1.5
1.27
22
125
(3012516) Albumin [Mass/volume] in Urine
410
4420
0.90
1.04
3.4
3.2
mg/l
986.1
164.3
1.65
268
2823
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
215
0.60
1.03
1.4
2.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
60
1.84
1.03
1.7
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
85
700
1.23
1.02
2.4
2.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
41
307
1.34
1.02
4.2
2.9
mmol/l
7.1
7.6
0.64
41
294
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
91
1.65
1.00
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
176
0.57
1.00
1.3
1.9
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
35
2.00
1.00
1.3
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
18
115
1.57
0.99
1.3
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
29
0.00
0.97
0.0
6.4
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
31
0.00
0.96
0.0
2.4
—
3.2
—
0
12
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
141
1.50
0.95
1.0
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
27
2.23
0.93
1.2
2.1
mmol/l
1.2
1.2
—
6
27
(3000492) Spirometry study
116
996
1.18
0.92
1.6
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
42
1.91
0.88
1.1
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
42
1.91
0.88
7.7
7.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
79
1.65
0.88
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
79
1.65
0.88
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
79
1.65
0.88
1.0
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1156
11286
1.10
0.86
4.6
4.6
mu/l
4.4
2.1
0.47
1040
10127
(3000330) Specific gravity of Urine by Test strip
83
698
1.20
0.85
3.6
3.7
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
6
111
0.54
0.83
1.5
2.1
ug/l
1.5
1.8
—
6
97
(3026470) Cobalt [Mass/volume] in Blood
6
115
0.52
0.82
1.5
2.0
ug/l
1.7
3.1
—
6
105
(3008037) Lactate [Moles/volume] in Venous blood
42
328
1.29
0.82
4.1
2.8
mmol/l
1.6
1.6
0.13
42
315
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
12
73
1.65
0.81
1.4
1.8
nmol/l
16.1
17.5
0.24
12
60
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
82
1.59
0.78
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
82
1.59
0.78
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
82
1.59
0.78
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
314
0.73
0.76
1.3
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
24
2.09
0.74
2.6
4.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
302
2804
1.10
0.73
5.1
4.1
kg/l
1.0
1.0
1.02
51
418
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
31
401
0.77
0.73
1.4
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
39
1.80
0.72
2.4
1.2
ug/l
12.8
9.2
—
7
39
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
142
1.41
0.72
1.2
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
14
206
0.68
0.71
1.4
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
40
1.75
0.71
1.3
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
17
239
0.71
0.69
1.8
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
200
1826
1.11
0.68
14.4
6.9
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
77
1.56
0.68
2.2
1.6
—
—
—
0
0
(4015189)
7
42
1.67
0.68
1.0
2.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
38
302
1.26
0.68
4.5
3.4
mg/l
26.5
28.5
0.16
26
196
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
70
1.58
0.65
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
70
1.58
0.65
1.1
1.0
—
—
—
0
0
(4094501)
28
360
0.77
0.65
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
181
1981
0.90
0.64
1.2
1.3
iu/ml
60.4
41.3
0.41
59
616
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
12
177
0.68
0.63
1.1
1.5
%
77.0
66.0
—
6
116
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
87
1.50
0.63
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
106
1195
0.88
0.62
1.5
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
28
358
0.78
0.62
2.0
1.6
e6/l
15017.8
12245.7
0.30
19
262
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
11
71
1.55
0.62
1.2
1.3
u/l
30.8
31.6
0.03
11
46
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
316
2968
1.08
0.60
2.7
2.7
ug/l
0.8
0.7
0.67
220
2038
(3004616) Nuclear Ab [Presence] in Serum
11
162
0.68
0.58
2.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
27
339
0.79
0.54
1.5
1.7
—
—
—
0
0
(4024509)
17
125
1.36
0.53
1.2
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
74
1.49
0.53
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
74
1.49
0.53
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
47
397
1.19
0.52
1.6
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
12
84
1.43
0.49
11.8
13.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
434
4529
0.94
0.49
3.2
3.2
mmol/l
7.1
7.5
1.21
360
3794
(3011288) Drugs identified in Urine by Screen method
15
110
1.37
0.48
1.0
3.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
15
113
1.33
0.42
1.1
1.3
—
31.4
—
0
5
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
12
87
1.38
0.42
1.3
1.5
umol/l
20.1
13.8
2.01
12
78
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
52.5
—
0
16
(3021788) Differential panel - Synovial fluid
21
260
0.81
0.40
1.4
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
19
0.00
0.39
0.0
1.3
—
6.3
—
0
9
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
108
1166
0.92
0.34
1.9
1.7
%
1.6
1.6
0.25
85
991
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
145
1.24
0.33
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
100
1.30
0.33
21.4
1.9
%
11.9
11.0
0.27
13
100
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
166
0.78
0.33
1.1
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
164
0.79
0.30
1.1
1.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
55
1.27
0.30
1.0
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
441
4282
1.04
0.30
4.0
3.8
%
22.4
24.1
1.46
225
2078
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
247
2367
1.05
0.29
1.2
1.2
u/ml
2.0
1.9
0.02
54
627
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
62
1.29
0.28
1.0
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
67
1.20
0.26
1.6
1.2
nmol/l
112.8
149.3
—
8
67
(3027944) Amphetamines [Presence] in Urine
14
171
0.82
0.26
1.1
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
23
197
1.17
0.26
2.1
1.6
mu/l
377.9
291.0
0.63
23
180
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
77
1.17
0.24
1.3
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
40
1.25
0.22
1.0
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
15
178
0.84
0.22
1.5
1.2
nmol/l
0.8
0.6
0.23
15
168
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(44806071)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
91
857
1.07
0.21
1.1
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
80
1.25
0.20
2.0
1.4
g/l
1.0
0.9
—
10
80
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
43.9
—
0
14
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
36
328
1.10
0.18
1.8
1.7
nmol/l
52.4
42.8
1.17
36
308
(3013139) Helicobacter pylori Ag [Presence] in Stool
74
783
0.94
0.17
1.2
1.3
—
—
—
0
0
(44813793)
5
67
0.75
0.17
1.0
1.0
—
—
—
0
0
(4211845)
5
70
0.71
0.16
3.2
4.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
27
244
1.11
0.16
1.1
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
51
477
1.07
0.15
1.1
1.1
titre
—
353.7
—
0
11
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
160
0.87
0.14
1.5
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
13
113
1.15
0.13
2.7
2.2
u/field
1.4
2.6
—
5
42
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
28
304
0.92
0.13
1.5
1.2
u/ml
2.5
4.9
—
5
51
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
10
116
0.86
0.12
1.0
1.0
ng/l
44.2
49.6
—
5
70
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
28
300
0.93
0.10
1.5
1.2
u/ml
1.5
3.1
—
5
27
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
61
636
0.96
0.10
1.2
1.2
iu/ml
157.3
127.6
0.17
23
244
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
155
0.90
0.09
1.5
1.2
nmol/l
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
64
0.78
0.08
3.2
4.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
65
1.08
0.08
1.3
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
171
1741
0.98
0.07
4.2
4.9
%
31.9
32.9
0.51
126
1116
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
40
382
1.05
0.07
2.0
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
31
294
1.06
0.07
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
84
0.83
0.07
1.6
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
173
0.92
0.06
1.1
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
173
0.92
0.06
1.1
1.9
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
40
384
1.04
0.06
3.2
2.3
ug/min
153.5
87.1
0.43
23
236
(4034850)
44
456
0.96
0.06
10.7
10.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
31
297
1.04
0.05
2.1
2.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
171
0.93
0.05
1.1
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1236
12344
1.01
0.02
5.1
5.0
mmol/l
6.0
6.1
0.35
1116
11082
(3032773) Endomysium IgG Ab [Titer] in Serum
10
93
1.08
0.02
1.1
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
16
153
1.05
0.01
1.2
1.4
pmol/l
200.9
295.9
1.06
11
117
(3022621) pH of Urine by Test strip
84
848
0.99
0.01
3.5
3.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1004
10030
1.00
0.01
50.1
18.3
g/l
331.3
332.4
3.89
994
9947
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
174
0.98
0.00
1.7
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
135
0.96
0.00
1.1
2.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2.7
—
0
5
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
9
0.00
0.00
0.0
15.6
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.2
—
7.7
—
0
5
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
68
0.88
0.00
1.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
88
0.91
0.00
1.0
1.3
promille
1.2
1.1
—
8
70
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
70
1.00
0.00
2.1
2.6
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
10.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
80
1.00
0.00
1.8
1.5
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
1.2
—
0
6
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
130
1.00
0.00
1.4
1.4
%
12.5
25.1
—
8
85
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.6
—
357.7
—
0
9
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
84
0.95
0.00
1.0
2.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_DLBCL_EXALLC – Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)
GWS hits: 2
This endpoint is excluded (different definition than used in FinnGen).